Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2025-12-26 @ 9:38 AM
Study NCT ID:
NCT01114503
Status:
TERMINATED
Last Update Posted:
2020-10-30
First Post:
2010-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2012-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08-29
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-29
First Submit QC Date:
None
Study First Post Date:
2010-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-02
Results First Submit QC Date:
None
Results First Post Date:
2017-08-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-08
Last Update Post Date:
2020-10-30
Last Update Post Date Type:
ACTUAL